Skip to content
Use caution Drug recall · FDA · Published October 9, 2018

Lupin Recalls Testosterone Topical Solution Due to Defective Pump

Lupin Pharmaceuticals recalls specific lots of Testosterone Topical Solution because the pump may not work. Check your bottle's lot number and expiration date.

🇺🇸 FDA recall #D-0087-2019DrugLupin Pharmaceuticals ›
Take action

Contact the company

Recalling firmLupin Pharmaceuticals Inc.111 S Calvert St Fl 21ST · Baltimore, MD 21202-6174
✎ GovInfoNow plain-language explainer

What happened, in plain English

Lupin Pharmaceuticals Inc. has recalled 6,752 bottles of Testosterone Topical Solution (30mg/1.5mL) due to a defective container issue. The recall was initiated after receiving repetitive complaints that the pump mechanism on the bottles was not working properly. This defect prevents users from dispensing the medication as intended. Read more at govinfonow.com/recall/39511-lupin-recalls-testosterone-topical-solution-due-to-defective-pump.

Source Summary by GovInfoNow · govinfonow.com/recall/39511-lupin-recalls-testosterone-topical-solution-due-to-defective-pump · Updated October 11, 2026 · FDA enforcement record: FDA #D-0087-2019

Cite this page

“Lupin Recalls Testosterone Topical Solution Due to Defective Pump.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/39511-lupin-recalls-testosterone-topical-solution-due-to-defective-pump. Based on FDA recall #D-0087-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0087-2019%22&limit=1).

Why it’s dangerous

The primary hazard is a defective container where the pump fails to function. This does not pose a direct physical injury risk like fire or laceration, but it renders the product unusable, potentially leading to missed doses of necessary medication.

Who’s affected

Individuals who have purchased Testosterone Topical Solution manufactured by Lupin Pharmaceuticals Inc. between the relevant production dates and before the expiration of November 2019. These are likely patients prescribed this specific Rx medication for testosterone replacement therapy.

How to tell if you have this one

Look for 110mL bottles of Testosterone Topical Solution, Rx only, manufactured by Lupin Pharmaceuticals Inc. in Baltimore, Maryland. Check the label for NDC 68180-943-11 and lot numbers K700085 or K700087 with an expiration date of November 2019.

  • Brand
    Lupin Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle matches the recalled NDC 68180-943-11 and lot numbers K700085 or K700087.

  2. Contact Your Pharmacist

    If you have the recalled product, contact your pharmacy or healthcare provider to discuss replacement options since no specific remedy is listed in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Oct 9, 201812. FDA classified it Class III: Oct 23, 201823. Published in FDA’s Enforcement Report: Oct 31, 201834. FDA terminated the recall: Dec 16, 2019420182019
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How many bottles are being recalled?

A total of 6,752 bottles are included in this recall.

Similar recalls

Other Lupin Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0087-2019 (October 9, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0087-2019 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA